The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus

Cancer

Volumn 82, Issue 7, 1998, Pages 1225-1232

  Igarashi, Masahiko ^a   Dhar, Dipok Kumar ^a   Kubota, Hirofumi ^a   Yamamoto, Akitaka ^a   El Assal, Osama ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; CD34; Esophagus; Microvessel density; Prognostic factor; Squamous cell carcinoma; Thymidine phosphorylase

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CELL DENSITY; ENDOTHELIUM CELL; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE;

EID: 0032055524     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E     Document Type: Article

References (44)

1. Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma. Cancer 1996;78:1820-8.
2. Sabiston DC, Lyerly HK. Textbook of surgery: the biological basis of modern surgical practice: 15th edition. Philadelphia: W. B. Saunders, 1997:747-58.
3. Folkman J. Tumor angiogenesis: therapeutic implication. N Engl J Med 1971;285:1182.
4. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235:442-7.
5. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988;133:419-23.
6. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti C. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
7. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
8. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 1994;32:588-94.
9. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994;168:373-80.
10. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 1995;104:724-9.
11. Rutgers JL, Mattox TF, Vargas MP. Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol 1995; 14:114-8.
12. Tahan SR, Stein AL. Angiogenesis in invasive squamous cell carcinoma of the lip: tumor vascularity is not an indicator of metastatic risk. J Cutan Pathol 1995;22:236-40.
13. Wigging DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995;56:353-6.
14. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, et al. Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer. J Urol 1995;154:69-71.
15. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995;17:312-8.
16. Penfold CN, Partridge M, Rojas R, Langdon JD. The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1996;34:37-41.
17. Meitar DM, Crawford SE, Rademaker AW, Cohn SL. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 1996;14:405-14.
18. Porschen R, Classen S, Piontek M, Borchard F. Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res 1994;54:587-91.
19. Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert H. Tumor vascularization and prognosis in squamous cell carcinoma of the esophagus. Anticancer Res 1996;16:2117-22.
20. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, et al. Tumor vasucularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 1997;79:220-5.
21. Leung DW, Cachlanes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
22. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
23. Anan K, Morisaki T, Katano M, Ikobe A, Kitsuki H, Uchiyama A, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996;119:333-9.
24. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;87:1237-45.
25. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type. Clin Cancer Res 1996;2:1679-84.
26. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S. Angiogenic factor. Nature 1992;356:668.
27. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62.
28. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, et al. Angiogenic activity of enzymes. Nature 1994;368:198.
29. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995;64:79-82.
30. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 1996;88:1146-51.
31. Mizutani Y, Okada Y, Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 1997;79:1190-4.
32. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996;87:288-95.
33. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996;73:884-8.
34. Takebavashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 1996;32A:1227-32.
35. Beahrs O, Henson DE, Hutter RVP, Kennedy BI, editors. Manual for staging of cancer. 4th edition. American Joint Committee Against Cancer. Philadelphia: J. B. Lippincott, 1992.
36. World Health Organization. Histological typing of oesophageal and gastric tumours. Berlin: Springer, 1990:2.
37. Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 1996;73:931-4.
38. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
39. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients: brief communication. J Natl Cancer Inst 1977;58: 1587-90.
40. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86: 353-64.
41. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 1997;79:206-13.
42. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510-3.
43. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal cancer. J Natl Cancer Inst 1996;88:1110-7.
44. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acid and basic fibroblast growth factor, tumor growth factor b-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-9.